Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ResMed Inc. (RMD)

NYSE - NYSE Delayed Price. Currency in USD
215.95+2.43 (+1.14%)
At close: 04:00PM EDT
215.95 +0.07 (+0.03%)
After hours: 04:02PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/30/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3253.67
52 Week Low 3189.40
50-Day Moving Average 3217.76
200-Day Moving Average 3220.48

Share Statistics

Avg Vol (3 month) 3651.63k
Avg Vol (10 day) 3603.93k
Shares Outstanding 5146.91M
Implied Shares Outstanding 6N/A
Float 8145.5M
% Held by Insiders 11.31%
% Held by Institutions 165.52%
Shares Short (Jan 12, 2023) 4849.96k
Short Ratio (Jan 12, 2023) 41.33
Short % of Float (Jan 12, 2023) 40.66%
Short % of Shares Outstanding (Jan 12, 2023) 40.58%
Shares Short (prior month Dec 14, 2022) 4950.06k

Dividends & Splits

Forward Annual Dividend Rate 41.76
Forward Annual Dividend Yield 40.80%
Trailing Annual Dividend Rate 31.56
Trailing Annual Dividend Yield 30.73%
5 Year Average Dividend Yield 40.97
Payout Ratio 431.33%
Dividend Date 3Mar 15, 2023
Ex-Dividend Date 4Feb 07, 2023
Last Split Factor 22:1
Last Split Date 3Aug 30, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2022
Most Recent Quarter (mrq)Dec 30, 2022

Profitability

Profit Margin 21.51%
Operating Margin (ttm)28.03%

Management Effectiveness

Return on Assets (ttm)11.55%
Return on Equity (ttm)23.52%

Income Statement

Revenue (ttm)3.76B
Revenue Per Share (ttm)25.70
Quarterly Revenue Growth (yoy)15.50%
Gross Profit (ttm)2.06B
EBITDA 1.18B
Net Income Avi to Common (ttm)809.47M
Diluted EPS (ttm)3.13
Quarterly Earnings Growth (yoy)11.50%

Balance Sheet

Total Cash (mrq)258.18M
Total Cash Per Share (mrq)1.76
Total Debt (mrq)1.94B
Total Debt/Equity (mrq)51.88
Current Ratio (mrq)3.17
Book Value Per Share (mrq)18.62

Cash Flow Statement

Operating Cash Flow (ttm)370.22M
Levered Free Cash Flow (ttm)124.38M
Advertisement
Advertisement